Skip Navigation U.S. Department of Health and Human Services www.hhs.gov/
Agency for Healthcare Research Quality www.ahrq.gov
www.ahrq.gov/

Director's Update


Little Evidence for Some ‘Off-Label' Uses of Atypical Antipsychotic Drugs

Text Description is below the image.

  • Effective Health Care Program report shows little evidence to support off-label use of atypical antipsychotic medications (APMs) for substance abuse, eating disorders, or insomnia.
  • Evidence does support use of some atypical APMs for dementia, anxiety, and obsessive-compulsive disorder.

http://www.effectivehealthcare.ahrq.gov

Image: The first page of the executive summary for the off-label use of atypical antipsychotic medications report is shown.


Previous Slide Previous Slide         Contents         Next Slide Next Slide


 

AHRQAdvancing Excellence in Health Care